Exforge (Amlodipine Besylate / Valsartan) - Current Clinical Trials

Exforge Related Clinical Trials

Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)

Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension [Completed]

Effectiveness of EXforge® and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients [Recruiting]

Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Patients With Hypertension. [Completed]

The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction

One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension [Completed]

EXforge As Compared to Losartan Treatment in Stage 2 Systolic Hypertension [Recruiting]

Clinical Trial to Evaluate the Bioavailability and Safety of AGSAV301 [Recruiting]

Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive Patients [Recruiting]

Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects [Recruiting]

Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) Trial [Recruiting]

Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients [Completed]

Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension [Completed]

The Effects of Moderate and Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy [Recruiting]

Efficacy and Safety of Valsartan and Amlodipine in Adults With Moderate, Inadequately Controlled Hypertension [Active, not recruiting]

Demonstrate Non-inferiority of Combination of 5 mg Amlodipine and 80 mg Valsartan to 160 mg Valsartan [Recruiting]

A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on Monotherapy [Completed]

A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension [Completed]